EE200200271A - Ravimkombinatsioonid ning nende kasutamine - Google Patents

Ravimkombinatsioonid ning nende kasutamine

Info

Publication number
EE200200271A
EE200200271A EEP200200271A EEP200200271A EE200200271A EE 200200271 A EE200200271 A EE 200200271A EE P200200271 A EEP200200271 A EE P200200271A EE P200200271 A EEP200200271 A EE P200200271A EE 200200271 A EE200200271 A EE 200200271A
Authority
EE
Estonia
Prior art keywords
combinations
medicinal products
medicinal
products
Prior art date
Application number
EEP200200271A
Other languages
English (en)
Inventor
Dixon John
Humphries Robert
Jarvis Gavin
Kirk Ian
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200271A publication Critical patent/EE200200271A/et
Publication of EE05127B1 publication Critical patent/EE05127B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200271A 1999-12-01 2000-11-29 Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis EE05127B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904377A SE9904377D0 (sv) 1999-12-01 1999-12-01 Pharmaceutical combinations
PCT/SE2000/002378 WO2001039781A1 (en) 1999-12-01 2000-11-29 Pharmaceutical combinations

Publications (2)

Publication Number Publication Date
EE200200271A true EE200200271A (et) 2003-06-16
EE05127B1 EE05127B1 (et) 2009-02-16

Family

ID=20417947

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200271A EE05127B1 (et) 1999-12-01 2000-11-29 Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis

Country Status (33)

Country Link
US (2) US20030032618A1 (et)
EP (2) EP1719526A3 (et)
JP (1) JP2003515565A (et)
KR (1) KR100785953B1 (et)
CN (1) CN1402639A (et)
AR (1) AR033658A1 (et)
AT (1) ATE332698T1 (et)
AU (1) AU781691B2 (et)
BR (1) BR0016043A (et)
CA (1) CA2391161C (et)
CO (1) CO5271717A1 (et)
CY (1) CY1105211T1 (et)
CZ (1) CZ300925B6 (et)
DE (1) DE60029340T2 (et)
DK (1) DK1237559T3 (et)
EE (1) EE05127B1 (et)
ES (1) ES2267591T3 (et)
HK (1) HK1047893A1 (et)
HU (1) HU230890B1 (et)
IL (1) IL149495A0 (et)
IS (1) IS2841B (et)
MX (1) MXPA02004871A (et)
MY (1) MY128896A (et)
NO (1) NO331215B1 (et)
NZ (2) NZ530058A (et)
PT (1) PT1237559E (et)
RU (1) RU2242232C2 (et)
SE (1) SE9904377D0 (et)
SI (1) SI1237559T1 (et)
SK (1) SK288707B6 (et)
TW (1) TWI251491B (et)
WO (1) WO2001039781A1 (et)
ZA (1) ZA200203707B (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
EP1604669A1 (en) * 2004-06-10 2005-12-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of ATP analogues for treatment of cardiovascular diseases
CN101253179B (zh) * 2005-09-21 2010-12-29 株式会社钟根堂 S-氯吡格雷的树脂酸盐复合物及其制备方法
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US20120141468A1 (en) 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
PT2498731T (pt) 2009-11-11 2020-02-21 Chiesi Farm Spa Métodos de tratamento ou prevenção de uma trombose de endoprótese
CN103582480B (zh) 2011-02-09 2016-03-16 医药公司 治疗肺高压的方法
PL2964233T3 (pl) 2013-03-09 2022-04-25 Chiesi Farmaceutici S.P.A. Sposoby leczenia, zmniejszania częstości występowania i(lub) profilaktyki zdarzeń niedokrwiennych
KR20200018481A (ko) 2017-06-23 2020-02-19 키에시 파르마슈티시 엣스. 피. 에이. 체폐동맥 션트 혈전증의 예방 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
CA2107667A1 (en) * 1991-04-06 1992-10-07 Anthony Howard Ingall Atp analogues
PL175623B1 (pl) * 1993-02-10 1999-01-29 Astra Pharma Prod N-alkilo-2-podstawione analogi ATP, sposób ich wytwarzania i kompozycja farmaceutyczna je zawierająca
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
PL182680B1 (pl) * 1995-07-11 2002-02-28 Astrazeneca Ab Nowe inhibitory skupiania się płytek krwi
CA2332608C (en) * 1998-06-17 2010-03-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US6696468B2 (en) * 2002-05-16 2004-02-24 Dainippon Pharmaceutical Co., Ltd. (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
WO2005007191A1 (ja) * 2003-07-16 2005-01-27 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物

Also Published As

Publication number Publication date
AU1910901A (en) 2001-06-12
PT1237559E (pt) 2006-10-31
ES2267591T3 (es) 2007-03-16
SK7502002A3 (en) 2003-02-04
CZ300925B6 (cs) 2009-09-09
RU2002117296A (ru) 2004-01-20
EP1719526A2 (en) 2006-11-08
IS2841B (is) 2013-08-15
IS6398A (is) 2002-05-27
US20060270607A1 (en) 2006-11-30
CN1402639A (zh) 2003-03-12
BR0016043A (pt) 2002-07-23
CO5271717A1 (es) 2003-04-30
EE05127B1 (et) 2009-02-16
EP1719526A3 (en) 2007-04-25
NZ530058A (en) 2005-04-29
CZ20021887A3 (cs) 2002-11-13
NO20022606D0 (no) 2002-05-31
IL149495A0 (en) 2004-03-28
AU781691B2 (en) 2005-06-09
SE9904377D0 (sv) 1999-12-01
KR100785953B1 (ko) 2007-12-14
MXPA02004871A (es) 2002-08-30
TWI251491B (en) 2006-03-21
WO2001039781A1 (en) 2001-06-07
DK1237559T3 (da) 2006-10-30
EP1237559B1 (en) 2006-07-12
PL355841A1 (en) 2004-05-17
RU2242232C2 (ru) 2004-12-20
MY128896A (en) 2007-02-28
NO20022606L (no) 2002-07-11
HU230890B1 (hu) 2018-12-28
NZ518904A (en) 2004-02-27
HUP0203585A3 (en) 2005-01-28
US20030032618A1 (en) 2003-02-13
NO331215B1 (no) 2011-11-07
ZA200203707B (en) 2003-10-29
ATE332698T1 (de) 2006-08-15
AR033658A1 (es) 2004-01-07
HUP0203585A2 (hu) 2003-03-28
DE60029340T2 (de) 2007-07-19
JP2003515565A (ja) 2003-05-07
CY1105211T1 (el) 2010-03-03
SK288707B6 (sk) 2019-10-02
SI1237559T1 (sl) 2007-02-28
HK1047893A1 (en) 2003-03-14
CA2391161C (en) 2010-10-05
KR20020069201A (ko) 2002-08-29
DE60029340D1 (de) 2006-08-24
CA2391161A1 (en) 2001-06-07
EP1237559A1 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
DE69938299D1 (de) Lokale abgabe von arzneimitteln
DE60005810D1 (de) Fussstütze und möbelstück
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
IS4839A (is) Nýjar bensazepín afleiður, læknislyf sem innihalda þær og notkun þeirra við að útbúa læknislyf
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
EE200200118A (et) Terapeutilised kinasoliini derivaadid, nende valmistamise meetod ning kasutamine
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
PL354168A1 (en) Pharmaceutical composition of nateglinide and another antidiabetcagent
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
EP1227821A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
ATE264680T1 (de) Beta-carbolin arzneistoffprodukte
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
GB9924334D0 (en) Pharmaceutical products and methods of fabrication therefor
DE60105565D1 (de) Stabiles und wirksames weiches feststoffprodukt
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231